These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26759185)

  • 21. Proton pump inhibitors and chronic kidney disease.
    Kamal F; Khan MA; Howden CW
    Kidney Int; 2017 Aug; 92(2):515. PubMed ID: 28709604
    [No Abstract]   [Full Text] [Related]  

  • 22. Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD.
    Xie Y; Bowe B; Li T; Xian H; Balasubramanian S; Al-Aly Z
    J Am Soc Nephrol; 2016 Oct; 27(10):3153-3163. PubMed ID: 27080976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proton Pump Inhibitors and Chronic Kidney Disease: Causation or Another False Alarm?
    Bjorkman DJ
    Gastroenterology; 2017 Sep; 153(3):638-640. PubMed ID: 28757269
    [No Abstract]   [Full Text] [Related]  

  • 24. Nephrotoxic potential of proton pump inhibitors.
    Arif F
    Eur J Intern Med; 2017 Jul; 42():e16. PubMed ID: 28377063
    [No Abstract]   [Full Text] [Related]  

  • 25. Proton Pump Inhibitors and CKD.
    Moledina DG; Perazella MA
    J Am Soc Nephrol; 2016 Oct; 27(10):2926-2928. PubMed ID: 27080978
    [No Abstract]   [Full Text] [Related]  

  • 26. Adverse Effects of Proton Pump Inhibitors in Chronic Kidney Disease.
    Ness-Jensen E; Fossmark R
    JAMA Intern Med; 2016 Jun; 176(6):868. PubMed ID: 27273497
    [No Abstract]   [Full Text] [Related]  

  • 27. Adverse Effects of Proton Pump Inhibitors in Chronic Kidney Disease.
    Iannuzzella F; Corradini M; Pasquali S
    JAMA Intern Med; 2016 Jun; 176(6):868-9. PubMed ID: 27273498
    [No Abstract]   [Full Text] [Related]  

  • 28. Adverse Effects of Proton Pump Inhibitors in Chronic Kidney Disease.
    Poesen R; Meijers B; Evenepoel P
    JAMA Intern Med; 2016 Jun; 176(6):867-8. PubMed ID: 27273496
    [No Abstract]   [Full Text] [Related]  

  • 29. Adverse Effects of Proton Pump Inhibitors in Chronic Kidney Disease.
    Zhao P; Wei Z; Han J
    JAMA Intern Med; 2016 Jun; 176(6):867. PubMed ID: 27273495
    [No Abstract]   [Full Text] [Related]  

  • 30. Adverse Effects of Proton Pump Inhibitors in Chronic Kidney Disease.
    Lozano R
    JAMA Intern Med; 2016 Jun; 176(6):866-7. PubMed ID: 27273494
    [No Abstract]   [Full Text] [Related]  

  • 31. Adverse Effects of Proton Pump Inhibitors in Chronic Kidney Disease.
    Fusaro M; Giannini S; Gallieni M
    JAMA Intern Med; 2016 Jun; 176(6):866. PubMed ID: 27273493
    [No Abstract]   [Full Text] [Related]  

  • 32. Adverse Effects of Proton Pump Inhibitors in Chronic Kidney Disease-Reply.
    Lazarus B; Coresh J; Grams ME
    JAMA Intern Med; 2016 Jun; 176(6):869-70. PubMed ID: 27273499
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacoepidemiology for nephrologists: do proton pump inhibitors cause chronic kidney disease?
    Tomlinson LA; Fogarty DG; Douglas I; Nitsch D
    Nephrol Dial Transplant; 2017 Apr; 32(suppl_2):ii40-ii46. PubMed ID: 28201528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there a relationship between hypomagnesemia and proton-pump inhibitors in patients on chronic hemodialysis?
    Mikolasevic I; Milic S; Stimac D; Zaputovic L; Lukenda Zanko V; Gulin T; Jakopcic I; Klaric D; Gulin M; Orlic L
    Eur J Intern Med; 2016 May; 30():99-103. PubMed ID: 26905320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proton Pump Inhibitors and Chronic Kidney Disease: Is It Related to the Accumulation of Toxic Breakdown Products Spontaneously Formed in the Enteric-Protected Tablets?
    Rudler M; Isnard Bagnis C; Rudler H
    Gastroenterology; 2018 Mar; 154(4):1204-1205. PubMed ID: 29452088
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-Term PPI Use: Balancing Potential Harms and Documented Benefits.
    Laine L; Nagar A
    Am J Gastroenterol; 2016 Jul; 111(7):913-5. PubMed ID: 27113114
    [No Abstract]   [Full Text] [Related]  

  • 37. PPIs and kidney disease: from AIN to CKD.
    Moledina DG; Perazella MA
    J Nephrol; 2016 Oct; 29(5):611-6. PubMed ID: 27072818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged utilization of proton pump inhibitors in patients with ischemic and valvular heart disease is associated with surgical treatments, weight loss and aggravates anemia.
    Boban M; Zulj M; Persic V; Medved I; Zekanovic D; Vcev A
    Int J Cardiol; 2016 Sep; 219():277-81. PubMed ID: 27343420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. When proton pump inhibitors are compared, are there specific cases in which a certain proton pump inhibitors should be particularly preferred?
    Çelebi A; Yılmaz H
    Turk J Gastroenterol; 2017 Dec; 28(Suppl 1):S68-S70. PubMed ID: 29199172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of the Prophylactic Use of Proton-Pump Inhibitors on the Pattern of Gastrointestinal Symptoms in Patients Late After Kidney Transplant.
    Królikowski J; Pawłowicz E; Budzisz E; Nowicki M
    Exp Clin Transplant; 2016 Oct; 14(5):503-510. PubMed ID: 27212101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.